
Nascent-stage investor (incubation through growth) partnering with founders at the technology–life sciences interface, focusing on drug discovery platforms, machine learning, tools, services, instruments and life-sciences software. The firm continues to build its presence across the venture capital landscape.
- Cheque size
- $1M – $10M
- Industries
- Operating in
- How they invest
- Not specified
- Technologies
- Not specified

